About 7.5 million Americans have psoriasis. But, despite psoriasis being a fairly common skin condition, it's often misunderstood. In case you're not familiar with it, psoriasis is a condition that ...
Add Yahoo as a preferred source to see more of our stories on Google. It’s important to pay attention to changes in your body, including new symptoms, because the earlier comorbidities are caught, the ...
Psoriasis patients typically experience a decreased quality of life and may have a higher risk of diabetes and heart disease. Is their oral health at risk too? The available evidence, mainly in the ...
Scott Gottlieb, MD, discusses the real-world outcomes of tildrakizumab for moderate to severe plaque psoriasis.
"Psoriasis is affecting millions globally, influencing not only skin health but also joints, overall immunity, and mental well-being," says Dr. Prachi B Bodkhe, dermatologist at Envi Aesthetics.
Phase 3 trial results show combined ixekizumab and tirzepatide therapy outperforms ixekizumab alone for patients with psoriasis and obesity or overweight.
PHILADELPHIA (CBS) -- A drug used to treat a common skin condition can also help people lose weight and reduce the risk of heart disease, new research from the University of Pennsylvania shows. Kim ...
Dating can be stressful to begin with, but navigating a new relationship while living with a visible skin disease, such as psoriasis, can bring up even more feelings of anxiety and insecurity. While ...
FDA approval introduces first-in-class, once-daily oral TYK2 inhibition for active psoriatic arthritis, expanding deucravacitinib beyond its 2022 plaque psoriasis indication. POETYK PsA-1 and PsA-2 ...
While each product featured is independently selected by our editors, we may include paid promotion. If you buy something through our links, we may earn commission. Read more about our Product Review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results